Please provide your email address to receive an email when new articles are posted on . More thorough understanding of giant cell arteritis disease processes has shed light on how immune checkpoint ...
Auto-reactive antibodies as predictive markers for immune checkpoint–induced pneumonitis. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full ...
Nivolumab treatment in advanced non-small cell lung cancer (NSCLC): Retrospective analysis of real-life data in the Hospital Universitario Reina Sofía (HURS). This is an ASCO Meeting Abstract from the ...
Immune checkpoint inhibitors (ICIs) are a type of immunotherapy or cancer treatment that targets specific immune cells known as T cells, which are responsible for eliminating infection. In cancer, T ...
Combination therapies, which target multiple immune checkpoints at once, have the potential to deliver improved outcomes for cancer patients. The development of clinically relevant predictive tools to ...